Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9302318 | 0.87 | CA12 (0.39) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL4206457 | 0.86 | CA12 (0.40) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL118162 | 0.86 | CA12 (0.42) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL28775410 | 0.85 | LMNA (0.43) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL23703121 | 0.84 | CA12 (0.42) | CA12CA1CA2CA9STAT3 | |
| Pyridine SCHEMBL6266454 | 0.84 | STAT3 (0.35) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL8871679 | 0.83 | STAT3 (0.43) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL1393935 | 0.83 | TSHR (0.44) | CA12CA1CA2CA9STAT3 | |
| SCHEMBL29667787 | 0.82 | CA2 (0.51) | CA12CA1CA2CA9ALDH1A1 | |
| SCHEMBL9063891 | 0.82 | CA12 (0.38) | CA12CA1CA2CA9STAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120022913-A | Method for using high-stability copper-based catalyst in hydrochlorination of acetylene | 中盐吉兰泰氯碱化工有限公司 | 2025-05-23 | — | — | CN | claimed |
| CN-119708059-A | Post-production treatment method for tenofovir | 石家庄龙泽制药股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-115974921-B | Synthetic tenor Fuwei method | 浙江嘉化新材料有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-118652277-A | Preparation method of compound for treating cancer diseases | 成都工业学院 | 2024-09-17 | — | — | CN | claimed |
| CN-118530274-A | Preparation method of diethyl p-toluenesulfonyloxy methylphosphonate | 江西永通科技股份有限公司 | 2024-08-23 | — | — | CN | claimed |
| CN-116854735-A | Synthesis method of tenofovir | 广西奕安泰药业有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-115974921-A | Method for synthesizing tenofovir | 浙江嘉化新材料有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-114843597-A | Flame-retardant self-repairing quasi-solid polymer electrolyte and preparation method thereof | 河北师范大学 | 2022-08-02 | — | — | CN | claimed |
| CN-215811163-U | Raw material weighing device is used in preparation of p toluene sulfonyl oxygen methyl phosphonic acid diethyl ester | 济南立德医药技术有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-215464416-U | Reaction kettle for preparing diethyl p-toluenesulfonyloxymethylphosphonate | 济南立德医药技术有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-108178772-B | Preparation method of tenofovir disoproxil fumarate intermediate | 上海博悦生物科技有限公司 | 2020-01-21 | — | — | CN | claimed |
| CN-108627647-A | A kind of detection of posttranslational modification proteomics and quantitative approach | 四川大学 | 2018-10-09 | — | — | CN | claimed |
| CN-106046055-A | R-9-(2-phosphonomethoxy propyl)-adenine monohydrate crystals, preparation thereof and preparation of tenofovir disoproxil fumarate | 湖北丽益医药科技有限公司 | 2016-10-26 | — | — | CN | claimed |
| CN-103641858-B | A kind of tenofovir disoproxil fumarate and preparation method thereof | HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL CO., LTD. (CN) | 2016-01-20 | — | — | CN | claimed |
| US-8759515-B2 | Process for the preparation of tenofovir disoproxil fumarate | MYLAN LABORATORIES LIMITED (IN) | 2014-06-24 | — | — | US | claimed |
| CN-103641858-A | Tenofovir disoproxil fumarate and preparation method thereof | HUNAN QIANJIN XIANGJIANG PHARM CO LTD | 2014-03-19 | — | — | CN | claimed |
| EP-2545063-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF TENOFOVIR DISOPROXIL FUMARATE | Matrix Laboratories Ltd (IN) | 2013-01-16 | — | — | EP | claimed |
| US-20130005969-A1 | PROCESS FOR THE PREPARATION OF TENOFOVIR DISOPROXIL FUMARATE | MYLAN LABORATORIES LIMITED (IN) | 2013-01-03 | — | — | US | claimed |
| WO-2011111074-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF TENOFOVIR DISOPROXIL FUMARATE | MATRIX LABORATORIES LTD (IN) | 2011-09-15 | — | — | WO | claimed |
| EP-1256585-A1 | Process fot preparing 9-(2-(diethylphosphonomethoxy)ethyl)-adenine | GILEAD SCIENCES, INC. (US) | 2002-11-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005969-A1 | PROCESS FOR THE PREPARATION OF TENOFOVIR DISOPROXIL FUMARATE | TYMP, PNP, MTAP | CA12 2586/4885CA1 2361/4885CA2 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.